STMN1 and gastric adenocarcinoma: Aberrant nuclear p53 expression was found in 51 (45.9%) of gastric adenocarcinomas and more frequently in STMN1-positive tumor (50.0%) than STMN1-negative tumor (20.0%) (p = 0.03).